{"organizations": [], "uuid": "6e5a63c71cb05ab5d91420bd3f5cb89ef74d2b1f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180409.html", "section_title": "Archive News &amp; Video for Monday, 09 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-yifan-pharma-to-acquire-technology/brief-yifan-pharma-to-acquire-technology-related-to-insulin-products-summitbioteck-co-ltd-idUSH9N1RA01T", "country": "US", "domain_rank": 408, "title": "BRIEF-Yifan Pharma To Acquire Technology Related To Insulin Products Summitbioteck Co Ltd", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-09T21:11:00.000+03:00", "replies_count": 0, "uuid": "6e5a63c71cb05ab5d91420bd3f5cb89ef74d2b1f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-yifan-pharma-to-acquire-technology/brief-yifan-pharma-to-acquire-technology-related-to-insulin-products-summitbioteck-co-ltd-idUSH9N1RA01T", "ord_in_thread": 0, "title": "BRIEF-Yifan Pharma To Acquire Technology Related To Insulin Products Summitbioteck Co Ltd", "locations": [], "entities": {"persons": [], "locations": [{"name": "hong kong", "sentiment": "none"}], "organizations": [{"name": "yifan pharmaceutical co ltd", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "insulin products summitbioteck co ltd", "sentiment": "negative"}, {"name": "ated", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9 (Reuters) - Yifan Pharmaceutical Co Ltd:\n* SAYS IT SIGNS AGREEMENT TO ACQUIRE TECHNOLOGY RELATED TO INSULIN PRODUCTS FOR ABOUT 250 MILLION YUAN ($39.62 million) FROM HONG KONG-BASED SUMMITBIOTECK CO LTD Source text in Chinese: bit.ly/2IGbnIh Further company coverage: ($1 = 6.3095 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://bit.ly/2IGbnIh", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-09T21:11:00.000+03:00", "crawled": "2018-04-10T12:44:04.027+03:00", "highlightTitle": ""}